CTIS2023-505971-66-00招募中1 期
Open-label, prospective study evaluating the efficacy and safety of Tirbanibulin 1% (Klisyri®) in the treatment of superficial basal cell carcinoma - 23-PP-04
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Male and female patients over 18 years of age., Patients with one or more primary, superficial BCCs of the trunk or limbs confirmed by LC-OCT., Primitive BCC, long axis less than or equal to 15 mm., Patient affiliated to a Social Security scheme., Patient likely to understand study instructions., Signed informed consent. If necessary, a legal representative can sign the consent form.
排除标准
- •BCC scalp and face, Recurrent BCC, Non-superficial BCC, BCC diameter > 15 mm, Patient allergic to Tirbanibulin to an excipient of the finished product, Treatment with cryotherapy, imiquimod, PDT, or radiotherapy in the treatment area within 6 months prior to the first visit, Pregnant or breast-feeding women (a urine pregnancy test will be performed), Current participation or less than 30 days' participation in a clinical drug trial, Any medical or psychiatric condition that could prevent the proper understanding and conduct of treatment and study (adults under guardianship)
研究者
相似试验
进行中（未招募）
1 期
Study analyzing the efficacy and safety of low-dose oral immunotherapy in children with severe allergy to cow's milk treated with Omalizumab. ILO studySevere IgE-mediated cow's milk allergyMedDRA version: 20.0Level: HLGTClassification code: 10021505Term: Immunology and allergy investigations Class: 10022891MedDRA version: 20.0Level: PTClassification code: 10016946Term: Food allergy Class: 100000004870MedDRA version: 20.0Level: LLTClassification code: 10076438Term: Milk protein allergy Class: 10021428MedDRA version: 20.0Level: LLTClassification code: 10001745Term: Allergy to cow's milk Class: 10021428MedDRA version: 20.0Level: LLTClassification code: 10011240Term: Cow's milk allergy Class: 10021428MedDRA version: 20.0Level: PTClassification code: 10027633Term: Milk allergy Class: 100000004870CTIS2023-503958-12-00Hospital Infantil Universitario Nino Jesus20
已完成
不适用
An open-label study evaluating the effectiveness of aripiprazole for schizophrenia patients with dopamine supersensitivity psychosis.Schizophrenia, Schizaffective disorderJPRN-UMIN000012574Department of Psychiatry, Chiba University Graduate School of Medicine20
招募中
不适用
Prospective study to assess the efficacy and safety of different doses of antihistamines in treating chronic spontaneous urticariaCTRI/2016/07/007099All India Institute of Medical Sciences96
招募中
3 期
Dizester a Herbal formulation for dyspepsiaCTRI/2021/09/036266Dr Willmar Schwabe India Pvt Ltd
招募中
2 期
Clinical research of intraperitoneal and intravenous paclitaxel plus S-1 in patients with recurrence of gastric cancer with peritoneal disseminatioJPRN-jRCTs061200027Fujihara Yoshiyuki20